Zenith Health Care Ltd.

4.58 +0.11 ▲2.5%

23 April 2024, 11:51:00 AM
Volume: 8,172

Company Profile

Sector Healthcare Sector Icon Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Industry Icon Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.zenithhealthcare.com
Market Cap 24.67 Cr.
Enterprise Value(EV) 22.80 Cr. 2023-09
Financial Indicators
Earnings per share (EPS) 0.05 Trailing Twelve Months Ending 2023-12
Price-Earning Ratio (PE) 98.27 Trailing Twelve Months Ending 2023-12
Industry PE 41.25 Trailing Twelve Months Ending 2023-12
Book Value / Share 1.43 Trailing Twelve Months Ending 2023-12
Price to Book Value 3.21 Calculated using Price: 4.59
Dividend Yield 0.00 Period Ending 2023-03
No. of Shares Subscribed 5.37 Cr. 53,739,000 Shares
FaceValue 1
About Zenith Health Care Ltd.
Zenith Healthcare is engaged in the manufacturing of tablets, capsules, ointments, and liquid injectable among others.

Zenith Health Care Ltd. Delivery

Delivered Qty
Traded Qty

Zenith Health Care Ltd. Performance

1 Day
+2.46%
1 Week
+2.92%
1 Month
+2.00%
3 Month
+6.02%
6 Month
+11.98%
1 Year
+11.44%
2 Year
-35.67%
5 Year
+84.68%
10 Year
+615.62%

Zenith Health Care Ltd. Fundamental Ratios

9 years 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03 2023-03
Return on Equity (%) -4.06 -5.45 -2.78 4.95 2.38 9.27 6.64 4.44 1.08
Return on Capital Employed (%) -5.82 -8.24 -3.04 7.38 2.95 9.68 8.56 8.85 1.74
Return on Assets (%) -3.73 -5 -2.55 4.37 2.03 7.6 5.28 3.11 0.75

Zenith Health Care Ltd. Balance Sheet

Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-09* Rs. Cr.
Shh. Funds 6 6 5 6 6 6 7 7 7 8
Non Curr. Liab. 0 0 0 0 0 0 0 0 0 0
Curr. Liab. 1 1 1 1 1 2 2 5 2 2
Minority Int.
Equity & Liab. 6 6 6 7 7 8 8 12 9 10
Non Curr. Assets 3 2 2 2 2 2 2 2 2 2
Curr. Assets 4 4 4 5 5 6 6 10 7 8
Misc. Exp. not W/O
Total Assets 6 6 6 7 7 8 8 12 9 10

Zenith Health Care Ltd. Profit and Loss

Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-12 Rs. Cr. TTM
Net Sales 4 3 5 10 10 12 14 22 13 13
Other Income 0 0 0 0 0 0 1 1 0 0
Total Income 4 4 5 10 10 12 14 23 14 13
Total Expenditure -4 -4 -5 -9 -10 -11 -13 -22 -13 -13
PBIDT 0 0 0 1 0 1 1 1 0 1
Interest 0 0 0 0 0 0 0 0 0
Depreciation 0 0 0 0 0 0 0 0 0 0
Taxation 0 0 0 0 0 0 0 0 0 0
Exceptional Items
PAT 0 0 0 0 0 1 0 0 0 0
Adjusted EPS 0 0 0 0 0 0 0 0 0 0

Zenith Health Care Ltd. Cash Flow

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Cash Fr. Operatn. 0 0 0 0 1 0 2 -1 1 -1
Cash Fr. Inv. 0 0 0 0 0 0 -1 0 0 0
Cash Fr. Finan. 0 0 0
Net Change -1 0 0 0 0 0 1 -2 1 -1
Cash & Cash Eqvt 0 0 1 1 1 1 2 1 2 1

Zenith Health Care Ltd. Shareholding Pattern

9 Qtrs 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%) 2023-06 (%) 2023-09 (%) 2023-12 (%) 2024-03 (%)
Promoter 28.74 28.74 28.74 28.74 28.74 28.74 28.74 28.74 28.74
Public 71.26 71.26 71.26 71.26 71.26 71.26 71.26 71.26 71.26
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
No. of Shareholders (in Lacs)

Zenith Health Care Ltd. Announcements

Thu, 11 Apr 2024
Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A
Format of Initial Disclosure to be made by an entity identified as a Large Corporate.

Sr. No. Particulars Details
1Name of CompanyZENITH HEALTH CARE LTD.
2CIN NO.L24231GJ1994PLC023574
3 Outstanding borrowing of company as on 31st March / 31st December as applicable (in Rs cr) 0.00
4Highest Credit Rating during the previous FY NA
4aName of the Credit Rating Agency issuing the Credit Rating mentioned in (4)Not Applicable
5Name of Stock Exchange# in which the fine shall be paid in case of shortfall in the required borrowing under the frameworkBSE


We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26 2018. No



Name of the Company Secretary: Mihir Shah
Designation: Company Secartary and Compliance Officer
EmailId: mahendrazenith@hotmail.com
Name of the Chief Financial Officer: Prashant Gupta
Designation: Chef Finanical Officer
EmailId: zenithaccounts@hotmail.com

Date: 11/04/2024

Note: In terms para of 3.2(ii) of the circular beginning F.Y 2022 in the event of shortfall in the mandatory borrowing through debt securities a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore an entity identified as LC shall provide in its initial disclosure for a financial year the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets.
Wed, 10 Apr 2024
Submission Of Share Transfer Etc. Certificate For The Year Ended 31St March 2024 Pursuant To Regulation 40(10) Of The SEBI (LODR ) 2015.
Submission of Share Transfer etc. Certificate for the year ended 31st March 2024 pursuant to Regulation 40 (10) of the SEBI (LODR) 2015.
Wed, 10 Apr 2024
Compliance Certificate Under Regulation 7(3) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 For The Financial Year Ended 31St March 2024
Compliance Certificate under Regulation 7(3) of the SEBI (Listing Obligation and Disclosure Requirnments) Regulation 2015 for the Financial Year ended 31st March 2024.

Zenith Health Care Ltd. Technical Scans

Mon, 22 Apr 2024
High Delivery Percentage High Delivery Percentage
5 SMA Crossing 20 SMA From Above 5 SMA Crossing 20 SMA From Above
William %R Trending Down William %R Trending Down
Bearish Engulfing Bearish Engulfing
Close Crossing 20 SMA From Above Close Crossing 20 SMA From Above

Zenith Health Care Ltd. Related Stocks

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 369,401.61 1,515.05 -1.6%
Cipla Ltd. 109,341.46 1,365.55 +0.8%
Dr. Reddy's Laboratories Ltd. 100,341.19 6,024.80 +0.1%
Divi's Laboratories Ltd. 99,176.41 3,745.10 +0.2%
Zydus Lifesciences Ltd. 96,543.12 951.25 -0.9%
Mankind Pharma Ltd. 93,651.57 2,399.95 +2.5%
Apollo Hospitals Enterprise Ltd. 89,650.45 6,219.40 -0.3%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 41.48 1,515.05 -1.6%
Cipla Ltd. Consolidated 2023-12 29.49 1,365.55 +0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 19.19 6,024.80 +0.1%
Divi's Laboratories Ltd. Consolidated 2023-12 71.71 3,745.10 +0.2%
Zydus Lifesciences Ltd. Consolidated 2023-12 32.46 951.25 -0.9%
Mankind Pharma Ltd. Consolidated 2023-12 54.22 2,399.95 +2.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-12 113.58 6,219.40 -0.3%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 5.92 1,515.05 -1.6%
Cipla Ltd. Consolidated 2023-12 4.22 1,365.55 +0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 3.73 6,024.80 +0.1%
Divi's Laboratories Ltd. Consolidated 2023-12 7.61 3,745.10 +0.2%
Zydus Lifesciences Ltd. Consolidated 2023-12 5.12 951.25 -0.9%
Mankind Pharma Ltd. Consolidated 2023-12 10.54 2,399.95 +2.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-12 13.27 6,219.40 -0.3%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 0.11 1,515.05 -1.6%
Cipla Ltd. Consolidated 2023-03 0.02 1,365.55 +0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 0.06 6,024.80 +0.1%
Divi's Laboratories Ltd. Consolidated 2023-03 0.00 3,745.10 +0.2%
Zydus Lifesciences Ltd. Consolidated 2023-03 0.07 951.25 -0.9%
Mankind Pharma Ltd. Consolidated 2023-03 0.02 2,399.95 +2.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 0.44 6,219.40 -0.3%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,515.05 -1.6%
Cipla Ltd. Consolidated 2023-03 12.85 1,365.55 +0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 6,024.80 +0.1%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,745.10 +0.2%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 951.25 -0.9%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 2,399.95 +2.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 6,219.40 -0.3%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,515.05 -1.6%
Cipla Ltd. Consolidated 2023-03 12.85 1,365.55 +0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 6,024.80 +0.1%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,745.10 +0.2%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 951.25 -0.9%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 2,399.95 +2.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 6,219.40 -0.3%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 43,885.68 1,515.05 -1.6%
Cipla Ltd. Consolidated 2023-03 22,753.12 1,365.55 +0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 24,669.70 6,024.80 +0.1%
Divi's Laboratories Ltd. Consolidated 2023-03 7,767.51 3,745.10 +0.2%
Zydus Lifesciences Ltd. Consolidated 2023-03 17,237.40 951.25 -0.9%
Mankind Pharma Ltd. Consolidated 2023-03 8,749.43 2,399.95 +2.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 16,612.50 6,219.40 -0.3%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 8,560.84 1,515.05 -1.6%
Cipla Ltd. Consolidated 2023-03 2,835.49 1,365.55 +0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 4,507.30 6,024.80 +0.1%
Divi's Laboratories Ltd. Consolidated 2023-03 1,823.38 3,745.10 +0.2%
Zydus Lifesciences Ltd. Consolidated 2023-03 2,001.90 951.25 -0.9%
Mankind Pharma Ltd. Consolidated 2023-03 1,309.68 2,399.95 +2.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 887.50 6,219.40 -0.3%

Zenith Health Care Ltd. FAQ's

What is Zenith Health Care share price?

Can I buy Zenith Health Care shares now?

What is the Market Cap of Zenith Health Care?

What are the key metrics to analyse Zenith Health Care?

What is the 52 Week High and Low of Zenith Health Care?

What is the trend of Zenith Health Care share price?